Kanagawa, Japan

Misato Yokoi

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Misato Yokoi: Innovator in Pharmaceutical Composition

Introduction

Misato Yokoi is a prominent inventor based in Kanagawa, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of drug products that enhance the effectiveness of existing medications. Her innovative work has led to the creation of a unique pharmaceutical tablet that addresses critical issues in drug dissolvability.

Latest Patents

Yokoi holds a patent for her invention titled "Dissolution properties of drug products containing olmesartan medoxomil." This pharmaceutical tablet combines olmesartan medoxomil and amlodipine besylate, featuring improved dissolvability. The composition includes (A) olmesartan medoxomil, (B) amlodipine besylate as active ingredients, and (C) a calcium-containing additive. Additionally, she has developed a method to enhance the dissolution properties of this pharmaceutical composition.

Career Highlights

Misato Yokoi is currently employed at Daiichi Sankyo Company, Limited, where she continues to advance her research and development efforts. Her work is instrumental in creating more effective pharmaceutical solutions that can significantly improve patient outcomes.

Collaborations

Yokoi collaborates with esteemed colleagues such as Shuichi Yada and Hideki Yano, contributing to a dynamic research environment that fosters innovation and excellence in pharmaceutical development.

Conclusion

Misato Yokoi's contributions to the pharmaceutical industry exemplify the impact of innovative thinking in drug development. Her work not only enhances the effectiveness of medications but also demonstrates the importance of collaboration in achieving groundbreaking advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…